EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Spinal Cord Stimulation for Refractory Visceral and Cardiovascular Conditions: A Narrative Review of Emerging Indications

Ravi S Sandhu, Vishva Natarajan, Caleb E Stewart, Rushna P Ali, Ji-Suk K Yoo

Journal of Pain Research · 2026-11 · Volume 19 · 1-18

DOI: 10.2147/jpr.s642362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pain Research, 2026-11. Verfasst von Ravi S Sandhu und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal cord stimulation (SCS) is increasingly being explored beyond established neuropathic pain indications, including in visceral pain, autonomic dysfunction, and cardiovascular conditions. We conducted a structured narrative review of English-language clinical studies published between 2000 and 2025 investigating SCS for visceral pain or autonomic dysfunction. A structured search limited to PubMed identified 112 articles, and reference-list review identified 16 more; of these, 31 studies met inclusion criteria after screening. Refractory angina had the strongest evidence base. Multiple trials showed improved symptom control and reduced nitroglycerin use. Additionally, historical data from a single randomized cohort of selected high-risk patients showed similar improvements in angina symptoms and quality of life, along with similar 5-year mortality after SCS and coronary artery bypass grafting. Smaller, mostly uncontrolled studies of chronic abdominal, pancreatic, and pelvic pain reported at least 50% pain reduction in most patients. However, the only sham-controlled trial, conducted in chronic pancreatitis, found no benefit during blinded stimulation. Functional improvements in neurogenic bowel were observed, but the evidence was limited by small sample sizes and the absence of controls. Studies of cardiac syndrome X and critical limb ischemia also reported symptomatic benefit, but large-scale validation is lacking. Overall, SCS shows potential clinical benefit in refractory visceral pain and cardiovascular conditions, particularly refractory angina. However, the evidence outside angina remains limited and heterogeneous. Large, multicenter randomized trials using standardized outcomes are needed to clarify long-term efficacy and better define the role of SCS in these emerging indications.

Zitieren

APA

Sandhu, R. S., Natarajan, V., Stewart, C. E., Ali, R. P., & Yoo, J. K. (2026). Spinal Cord Stimulation for Refractory Visceral and Cardiovascular Conditions: A Narrative Review of Emerging Indications. Journal of Pain Research, Volume 19, 1-18. https://doi.org/10.2147/jpr.s642362

Vancouver

Sandhu RS, Natarajan V, Stewart CE, Ali RP, Yoo JK. Spinal Cord Stimulation for Refractory Visceral and Cardiovascular Conditions: A Narrative Review of Emerging Indications. Journal of Pain Research. 2026;Volume 19:1-18. doi:10.2147/jpr.s642362

BibTeX
@article{Sandhu2026,
  author = {Sandhu, Ravi S and Natarajan, Vishva and Stewart, Caleb E and Ali, Rushna P and Yoo, Ji-Suk K},
  title = {Spinal Cord Stimulation for Refractory Visceral and Cardiovascular Conditions: A Narrative Review of Emerging Indications},
  journal = {Journal of Pain Research},
  year = {2026},
  volume = {Volume 19},
  pages = {1--18},
  doi = {10.2147/jpr.s642362}
}
Kostenlos starten →